Target intelligence / Profile preview

Transmembrane protein 132E (TMEM132E)

Target
TMEM132E
Molecular classification
Transmembrane protein, Other (not classified as receptor, enzyme, transporter, ion channel, or transcription factor)
01

Overview

Transmembrane protein 132E (TMEM132E) is a widely expressed type I transmembrane protein highly expressed in brain and inner ear tissues, particularly in inner hair cells, where it is implicated in structural and functional regulation of neurons and hair cell development[1][2][3]. Variants in TMEM132E are linked to autosomal recessive nonsyndromic hearing impairment (ARNSHI, DFNB99), and its main molecular function appears to involve connecting the extracellular matrix to the intracellular actin cytoskeleton through extracellular immunoglobulin-like and cohesion domains[1]. The precise molecular mechanism and additional physiological roles are under investigation, but it is not classified as a receptor, channel, enzyme, or classical drug target[2][5][3]. It may play a role in protein trafficking and membrane organization as suggested by some studies[6], and is used primarily as a genetic biomarker in hereditary deafness[1][3]. There are no known approved drugs targeting TMEM132E.

Other names
TMEM132EDFNB99Deafness, autosomal recessive 99 proteinTransmembrane protein family 132EENSG00000181291 (Ensembl)Q6IEE7 (UniProt)
02

Biological functions

Regulation of neuronal structure and functionInner ear hair cell development and functionPotential role in protein trafficking and membrane organization
03

Disease associations

Inherited deafness (autosomal recessive nonsyndromic hearing impairment, ARNSHI/DFNB99)Breast-ovarian cancer, familial 2 (reported, but not a primary or validated risk gene)Other (limited emerging data for other roles)
04

Biomarkers

Deafness, nonsyndromic, autosomal recessive 99 (DFNB99)Variants in TMEM132E as genomic biomarker for genetic hearing screening in affected families

Beyond the preview

Go deeper on Transmembrane protein 132E (TMEM132E).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 132E (TMEM132E).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call